Back
Perspective Therapeutics Vs. Atlassian Industry Stock Comparison
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.11
Seasonality Move:
26.28%
Buy
77
TEAM
Atlassian
Last Price:
219.05
Seasonality Move:
10.66%
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.09. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Atlassian (TEAM)
is a Buy
Is Atlassian a Buy, Sell or Hold?
- The current Atlassian [TEAM] share price is $224.35. The Score for TEAM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- TEAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TEAM Stock Price Chart
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 279101 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.94 - 13.14) | Sell |
Bollinger Bands (100): | (11.23 - 14.35) | Sell |
TEAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.65 | Buy |
Relative Strength Index (14 RSI): | 81.32 | Buy |
Chaikin Money Flow: | 3213055 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (167.26 - 197.54) | Buy |
Bollinger Bands (100): | (153.87 - 183.99) | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.78 | Buy |
20-day SMA: | 12.43 | Sell |
50-day SMA: | 13.5 | Sell |
200-day SMA: | 12.55 | Sell |
8-day EMA: | 11.94 | Buy |
20-day EMA: | 12.32 | Sell |
50-day EMA: | 12.87 | Sell |
200-day EMA: | 11.76 | Buy |
TEAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 193.81 | Buy |
20-day SMA: | 187.89 | Buy |
50-day SMA: | 172.54 | Buy |
200-day SMA: | 183.8 | Buy |
8-day EMA: | 197.13 | Buy |
20-day EMA: | 188.17 | Buy |
50-day EMA: | 177.53 | Buy |
200-day EMA: | 178.95 | Buy |
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Atlassian Earnings Growth & TEAM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.10 per share, and an increase next year of $0.40 per share.
Perspective Therapeutics Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Atlassian Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |